Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev • June 11, 2020
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Autoimmun Rev • June 11, 2020
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? Autoimmun Rev • May 11, 2020
Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome. Autoimmun Rev • April 7, 2020
Posterior reversible encephalopathy syndrome–Insight into pathogenesis, clinical variants and treatment approaches. Autoimmun Rev • October 30, 2015
Post-infectious group A streptococcal autoimmune syndromes and the heart. Autoimmun Rev • August 28, 2015